Catalyst Wire Dossier Catalyst Wire Dossier

Innate donor effector allogeneic lymphocyte infusion

· Rigshospitalet
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Innate donor effector allogeneic lymphocyte infusion, covering 2024-04-10 to 2024-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial [Phase 2, Phase 3]

See pricing